The Cooper Companies, Inc. $COO Holdings Decreased by Curi RMB Capital LLC

Key Points

• Curi RMB Capital LLC reduced its stake in The Cooper Companies by 7.4%, now holding approximately 0.18% of the company, valued at $30.25 million.
• Goldman Sachs Group increased its position in Cooper Companies by 17.0%, while other institutional investors also made significant adjustments to their holdings in the company.
• Analysts have set varying price targets for Cooper Companies, with an average target of $86.64, reflecting a "Moderate Buy" rating across multiple research firms.

Curi RMB Capital LLC trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 7.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 358,672 shares of the medical device company's stock after selling 28,865 shares during the quarter. Curi RMB Capital LLC owned approximately 0.18% of Cooper Companies worth $30,254,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in COO. Banque Transatlantique SA purchased a new position in shares of Cooper Companies in the first quarter worth $127,000. Amundi lifted its stake in Cooper Companies by 6.9% in the first quarter. Amundi now owns 982,828 shares of the medical device company's stock worth $76,828,000 after acquiring an additional 63,365 shares during the period. Adage Capital Partners GP L.L.C. lifted its position in shares of Cooper Companies by 111.7% during the first quarter. Adage Capital Partners GP L.L.C. now owns 182,160 shares of the medical device company's stock valued at $15,365,000 after buying an additional 96,100 shares during the last quarter. EP Wealth Advisors LLC lifted its position in shares of Cooper Companies by 177.2% during the first quarter. EP Wealth Advisors LLC now owns 12,300 shares of the medical device company's stock valued at $1,038,000 after buying an additional 7,862 shares during the last quarter. Finally, Twin Tree Management LP increased its holdings in Cooper Companies by 669.1% in the 1st quarter. Twin Tree Management LP now owns 4,553 shares of the medical device company's stock worth $384,000 after buying an additional 5,353 shares during the period. Hedge funds and other institutional investors own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on COO. BNP Paribas Exane upgraded Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 target price on the stock in a research report on Tuesday, July 22nd. Wells Fargo & Company lowered their price objective on Cooper Companies from $93.00 to $72.00 and set an "overweight" rating for the company in a research report on Thursday, August 28th. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $76.00 to $66.00 and set a "neutral" rating for the company in a research note on Thursday, August 28th. Needham & Company LLC reaffirmed a "buy" rating and set a $94.00 price objective on shares of Cooper Companies in a report on Thursday, August 28th. Finally, UBS Group raised Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $86.64.

Cooper Companies Stock Performance

Shares of NASDAQ COO traded up $0.70 during mid-day trading on Monday, hitting $68.79. The company had a trading volume of 3,555,929 shares, compared to its average volume of 2,300,499. The firm's 50 day simple moving average is $71.99 and its two-hundred day simple moving average is $76.57. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The stock has a market cap of $13.68 billion, a price-to-earnings ratio of 33.89, a PEG ratio of 1.72 and a beta of 0.97. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the previous year, the business earned $0.96 EPS. The firm's revenue for the quarter was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Insider Transactions at Cooper Companies

In other news, COO Daniel G. Mcbride acquired 3,000 shares of the company's stock in a transaction dated Tuesday, September 2nd. The shares were bought at an average price of $65.04 per share, with a total value of $195,120.00. Following the purchase, the chief operating officer owned 63,120 shares of the company's stock, valued at approximately $4,105,324.80. This represents a 4.99% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Albert G. White III acquired 10,000 shares of the company's stock in a transaction dated Friday, September 5th. The stock was purchased at an average cost of $68.39 per share, for a total transaction of $683,900.00. Following the purchase, the chief executive officer directly owned 226,151 shares in the company, valued at approximately $15,466,466.89. This represents a 4.63% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 15,975 shares of company stock worth $1,079,566 over the last 90 days. 1.98% of the stock is currently owned by corporate insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.